ArticleAIDS research and human retroviruses2020

Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options.

Karine Dubé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.